Roswell Park Comprehensive Cancer Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Roswell Park Comprehensive Cancer Center brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 2557. Its program centres on allogeneic stem cell transplant, with a focus on widening donor access and making transplant safer. It also covers menin inhibitors in acute myeloid leukemia and CAR T and T-cell engagers for myeloma.
| Organization | ASH 2026 Attendance |
|---|---|
Roswell Park Comprehensive Cancer Center Buffalo, NY | |
NCI-designated comprehensive cancer center in Buffalo, New York, founded in 1898, offering transplant, CAR T-cell therapy and cancer research. | Booth Exhibiting at Booth 2557 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 3:00pm–6:00pm Immune Therapy for Myeloma: From CAR T and T-Cell Engagers to Community Care Sequencing CAR-T and T-cell engagers for relapsed myeloma, when to refer, managing toxicity, and options after B-cell maturation antigen therapy fails. Symposium Fri Dec 11 3:00pm–6:00pm Live Hot Seat™: Advancing Precision Care in Acute Myeloid Leukemia With the Integration of Menin Inhibitors Menin inhibitors for genetically defined acute myeloid leukemia, covering patient selection, combinations, resistance, and differentiation syndrome. Session A Decade of Progress Towards Safer and More Broadly Applicable Allogeneic Stem Cell Transplantation How donor stem cell transplants became safer and more widely available, through better graft-versus-host disease prevention, new treatments, and more donor options. Talk Donor for All: Increasing Access and Improving Outcomes Expanding donor options with mismatched unrelated, half-matched family, and umbilical cord blood transplants, and evidence that outcomes hold up across donor types. |
Instantly find 20 buyers from Roswell Park Comprehensive Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction